Lestradet Prize for Education and Advocacy
The ISPAD Lestradet Prize for Education and Advocacy honors any ISPAD Member who has made an outstanding contribution to education and advocacy.
The ISPAD Lestradet Prize for Education and Advocacy is kindly supported by
The prize winner will be invited to attend ISPAD’s Annual Conference to officially receive the award at ISPAD’s Networking & Recognition Evening. ISPAD will cover registration, economy travel, and accommodation.
Previous winners
2025: Asma Deeb, United Arab Emirates
2024: Carine de Beaufort, Luxembourg
2023: Şükrü Hatun, Turkey
2022: Karin Lange, Germany
2021: Angie Middlehurst, UK, Australia
2020: Sheridan Waldron, UK
2019: Graham Ogle, Australia
2018: Ragnar Hanas, Sweden
2017: Lucy Mungai, Kenya
2016: Lynda Fisher, USA
2015: Harry Dorchy , Belgium
2014: Jean Jacques Robert, France
2013: Mona Salem, Egypt
2012: Mohammed Abdullah, Sudan
2011: Stuart Brink, USA
2010: Barbara Anderson, USA
2009: Viorel Şerban, Rumania
2008: François Bonnici, South Africa
2007: Marg McGill, Australia
2006: Peter Swift, UK
How to nominate for this prize?
Nominations for this category can be submitted by ISPAD members. A person can be nominated only by a third party, and no self-nominations will be accepted.
The nominator should provide all documents below (in English):
- A letter from the person/institution issuing the nomination specifying the reason for nomination. The letter should highlight the impact on the education of or advocacy for children with diabetes, the duration and extent (local, national, regional, or global) of the project/action, and the significance of the project/actions led by the nominee;
- A complete CV of the candidate.
Nominations for the 2025 ISPAD Prizes are closed. Thank you for celebrating excellence with us!
Send all the documents mentioned above to [email protected].
Eligibility criteria
- Current ISPAD member and ISPAD membership at least 80% of the last 5 years
- All professions
- Candidates can be from any country
- There are no age restrictions
Employment in the pharmaceutical sector may constitute a conflict of interest.
